Press Releases
Bioneer Signs Exclusive Supply Agreement with Brazil’s Med Solutions Ltda. for CosmeRNA
관리자 / 2024-12-31
Bioneer Signs Exclusive Supply Agreement with Brazil’s Med
Solutions Ltda. for CosmeRNA
- Strategic
partnership with Med Solutions Ltda., which boasts a network of over 10,000
hospitals
- Minimum
purchase commitment of USD 11.34 million over three years
Bioneer
announced on the 21st that it has signed a strategic partnership with Med
Solutions Ltda., one of Brazil’s leading medical device distributors, to secure
an exclusive supply agreement for its next-generation hair care product, CosmeRNA
ARI, in Brazil. Under this agreement, Bioneer will supply CosmeRNA through
Med Solutions Ltda.’s extensive network of over 10,000 hospitals across Brazil.
The
agreement stipulates that Med Solutions Ltda. will maintain its exclusive
supply rights by committing to a minimum purchase of USD 11.34 million over
three years. To maximize sales performance following the product launch, the
company plans to focus on aggressive sales and marketing efforts. This
partnership is expected to strengthen Bioneer’s position in the Brazilian hair
care market and ensure stable market entry and sustained growth.
Med
Solutions Ltda. plays a key role in Brazil’s medical and healthcare industries,
having established a strong presence with a nationwide hospital network and
reliable products and services. The company is anticipated to play a crucial
role in positioning CosmeRNA as an innovative hair loss management solution in
Brazil.
The
management of Med Solutions Ltda. showed significant interest in CosmeRNA,
completing negotiations promptly during a visit to Korea. Both companies are
preparing for a large-scale launch of CosmeRNA in Brazil, scheduled for March
next year.
The
Brazilian hair care market has experienced rapid growth recently, with
increasing awareness of hair loss issues among both men and women driving
market expansion. According to market research firm Data Bridge, the Brazilian
hair loss products market is projected to grow at a compound annual growth rate
(CAGR) of 3%, from approximately USD 132 million in 2023 to around USD 149
million by 2027.
Through
this agreement, Bioneer plans to introduce its B2B-exclusive product, CosmeRNA
Intensive, to the Brazilian market. The product will be launched through
hospitals and clinics across Brazil, offering a convenient and effective hair
loss management solution for both men and women struggling with hair loss.
A
Bioneer representative stated, “We are delighted to bring the innovative value
of CosmeRNA to Brazilian customers through this agreement. We will continue to
collaborate with companies with strong global customer networks to deliver
innovative products faster to markets worldwide.”